Biosimilars, Orphans, Advanced Therapy Medicines: Current regulatory issues (EU/US)

Biosimilars, Orphans, Advanced Therapy Medicines: Current regulatory issues (EU/US)
  • 14/01/2016
  • Michalopoulou & Associates

Get a quick, up to date overview of the Biotechnology industry and particularly “Red” Biotechnology and gain an understanding of the legal challenges the industry faces right now. Case studies, entrepreneurial examples and referrals to the current regulatory issues act as a starting point to delve deeper into that booming industry.

Leave a Comment

-->